A Clinical Trial to Evaluate the Safety and Efficacy of Centella asiatica for Ulcerative Colitis [0.03%]
评估 Centella asiatica 治疗溃疡性结肠炎安全性和有效性的临床试验
Xiangning Guo,Hirosumi Suzuki,Taku Sawafuji et al.
Xiangning Guo et al.
Aims: We previously reported that telomerase activator Centella asiatica (CA) can normalize the crypt structure of human colonic organoids in an ulcerative colitis (UC) model. Therefore, we aimed to evaluate the safety an...
Texture and Color Enhanced Imaging in the Diagnosis of Colonic Neoplasia: A Systematic Review and Analysis [0.03%]
结肠新生物诊疗中的纹理和色彩增强影像：系统性回顾与分析
Ciaran Judge,David Law,Glynis Jones et al.
Ciaran Judge et al.
Introduction: Image enhanced endoscopy (IEE) can augment the detection of colorectal cancer (CRC) and its precursor lesions, potentially reducing incidence and mortality. Early data on texture and color enhancement imagin...
Bioengineered Bile Duct for Liver Regenerative Medicine and Bile Duct Reconstruction [0.03%]
用于肝脏再生医学和胆管重建的生物工程化胆管
Peilin Li,Di Huang,Weili Gu et al.
Peilin Li et al.
Bioengineered tubular bile ducts are an emerging strategy in liver regenerative medicine and extrahepatic bile duct reconstruction, offering potential solutions to address biliary diseases and improve outcomes in liver transplantation. Diso...
Conservative Management Versus Early Cholecystectomy for Gallstone Disease: A Meta-Analysis of Randomized Controlled Trials [0.03%]
胆石病的保守治疗与早期胆囊切除术的 meta 分析研究
Kissan Ghose,Arooj Waheed,Samina Khan et al.
Kissan Ghose et al.
Objective: While most individuals with gallstone disease remain asymptomatic, symptoms of gallstone disease range from biliary pain to acute cholecystitis. Surgery is a popular choice of treatment, but evidence has also s...
Response Rate to Treatment of Achalasia Patients With Thyroid Disorders Versus Euthyroid Patients: A Cross-Sectional Study in Iran [0.03%]
甲状腺功能异常与甲状腺功能正常患者的食管失弛缓症治疗反应率：一项伊朗的横断面研究
Alireza Mehrban,Mehdi Karimi,Fatemeh Ahmadi Hajikolaei et al.
Alireza Mehrban et al.
Background: Achalasia, characterized by impaired esophageal motility, presents a challenge in diagnosis and management. Emerging evidence suggests a potential association between achalasia and thyroid disorders (TD). Unde...
Lymphocyte Fractions as Indicators of T-Helper 1/T-Helper 2 Cytokine Profiles in Inflammatory Bowel Disease [0.03%]
炎症性肠病中淋巴细胞亚群作为T辅助1/T辅助2型细胞因子谱系的指标
Yusuke Asai,Natsuki Ishida,Tomohiro Takebe et al.
Yusuke Asai et al.
Aims: Inflammatory bowel disease is characterized by various cytokine patterns. In this study, we aimed to investigate the markers that can distinguish Th1/Th2 cytokines in patients with inflammatory bowel disease. ...
A Sequential Combination of Baveno VI Criteria With Spleen Stiffness Measurement Improves the Screening of High-Risk Esophageal Varices in Compensated Advanced Chronic Liver Disease [0.03%]
Baveno VI标准联合脾硬度测量可提高代偿期肝硬化患者食管静脉曲张出血风险的筛查效能
Nichamon Suttitossatam,Sakkarin Chirapongsathorn,Kachonsak Yongwatana
Nichamon Suttitossatam
Background: Detecting high-risk esophageal varices (HRV) in cirrhotic patients is crucial for intervention and preventing variceal bleeding. While endoscopy is the gold standard for diagnosis, it is invasive and carries r...
Efficacy and Safety of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies [0.03%]
抗凝药物治疗肝硬化门静脉血栓疗效和安全性的系统评价和meta分析
Muhammad Hassan Waseem,Zain Ul Abideen,Marium Khan et al.
Muhammad Hassan Waseem et al.
Background: Portal vein thrombosis (PVT) contributes substantially to morbidity and mortality in cirrhotic patients. A clear insight into the anticoagulation therapy benefits in these patients could improve clinical decis...
A Tanousian,P Watanakunakorn,N Obad et al.
A Tanousian et al.
Introduction: Fecal occult blood testing (FOBT) is often ordered in emergency settings for patients presenting with hematemesis or hematochezia. However, FOBT is FDA-approved solely for colorectal cancer screening in the ...
Randomized, Placebo-Controlled, Double-Blind 8-Week Trial on the Efficacy of A Proprietary Kiwifruit Extract on Constipation-Predominant Irritable Bowel Syndrome [0.03%]
随机、双盲、安慰剂对照的便秘型肠易激综合征 kiwi 配制剂 8 周临床疗效研究
Gerald Holtmann,Nicholas J Talley,Sanjay Nandurkar et al.
Gerald Holtmann et al.
Background: Green kiwifruit (Actinidia deliciosa var Hayward) extract improves constipation. This study aimed to determine its efficacy in patients with constipation-predominant irritable bowel syndrome (IBS-C). ...